Skip to main content
PCVX logo

PCVX · Vaxcyte, Inc. · Webcasts, Transcripts & Audio

Track PCVX — free
$60.16 +1.64 (+2.80%) Play latest call Q4 2025 earnings call transcript
Market Cap
$9.26B
Shares
158.30M
Volume · Nov 19 172.87K Avg daily vol (3M) 2.16M

Vaxcyte, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Vaxcyte, Inc. (PCVX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Conference
Investor event
2026-11-18
Vaxcyte, Inc. (PCVX) November 18, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-11-10
Vaxcyte, Inc. (PCVX) November 10, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q3
2026-10-05
Vaxcyte, Inc. (PCVX) Q3 2026 Earnings Call
Diluted EPS
$-1.99
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-09-08
Vaxcyte, Inc. (PCVX) September 8, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Annual General Meeting
Investor event
2026-06-15
Vaxcyte, Inc. (PCVX) June 15, 2026 Annual General Meeting Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-06
Vaxcyte, Inc. (PCVX) Q1 2026 Earnings Call
Diluted EPS
$-2.30
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-24
Vaxcyte, Inc. (PCVX) Q4 2025 Earnings Call Transcript
Confident tone VAX-31 Adult Phase III (Opus) Program Infant Program (VAX-31 / VAX-24) Competitive Positioning vs. PCV20 and PCV21
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-04
Vaxcyte, Inc. (PCVX) Q3 2025 Earnings Call
Diluted EPS
$-1.56
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
Vaxcyte, Inc. (PCVX) Q2 2025 Earnings Call
Diluted EPS
$-1.22
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
Vaxcyte, Inc. (PCVX) Q1 2025 Earnings Call
Diluted EPS
$-1.04
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-31
Vaxcyte, Inc. (PCVX) Q4 2024 Earnings Call Transcript
Confident tone Infant pipeline and VAX-24/VAX-31 infant programs VAX-31 clinical progress and Phase 3 advancement ACIP recommendations and preferred status
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-05
Vaxcyte, Inc. (PCVX) Q3 2024 Earnings Call
Diluted EPS
$-0.83
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-08
Vaxcyte, Inc. (PCVX) Q1 2024 Earnings Call
Diluted EPS
$-0.85
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
Vaxcyte, Inc. (PCVX) Q4 2023 Earnings Call Transcript
Confident tone VAX-24 adult program VAX-31 adult program Regulatory and competitive landscape (V116, ACIP)
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q4
2023-04-17
Vaxcyte, Inc. (PCVX) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q4
2022-02-28
Vaxcyte, Inc. (PCVX) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q4
2021-03-29
Vaxcyte, Inc. (PCVX) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–17 of 17 webcasts
Key facts CIK 1649094 CUSIP 92243G108 13F (30d) 372 filings 338 filers Visit website Investor relations